+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Acute Respiratory Distress Syndrome Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by End-User, Mode of Administration, Treatment Mode, Region, By Country: 2020-2030

  • PDF Icon

    Report

  • 333 Pages
  • August 2024
  • Region: Global
  • Azoth Analytics
  • ID: 5993430
Description Jump to:
This report highlights different factors and opportunities prevailing in the “Global Acute Respiratory Distress Syndrome Market (2024 Edition)”. According to the report, the Global Acute Respiratory Distress Syndrome Market was valued at USD 356.66 Million and is expected to grow at a CAGR of 8.7% during 2025-2030.

The report explores a multi-faceted opportunity landscape in terms of market segmentation by End-User (Hospitals, Ambulatory Surgical Centers, Academic and Research Institutions, Specialty Clinics and Other End-Users), By Mode of Administration (Intravenous, Inhalation, Topical and Oral) and By Treatment Mode (Drugs and Devices)

Market Overview

The Acute Respiratory Distress Syndrome (ARDS) market has seen significant growth due to the rising incidence of ARDS, advancements in diagnostic and therapeutic technologies, and increasing awareness of critical care management. ARDS is a severe lung condition caused by various factors, including infections, trauma, and inhalation injuries, leading to respiratory failure. The market is driven by the need for effective treatments and management strategies to improve patient outcomes.

The COVID-19 pandemic has notably impacted the ARDS market, as severe COVID-19 cases often develop ARDS, increasing the demand for critical care treatments. The pandemic has heightened awareness of respiratory diseases and the importance of advanced healthcare infrastructure.

Advancements in medical technology, such as extracorporeal membrane oxygenation (ECMO) and non-invasive ventilation (NIV), have enhanced ARDS treatment. These technologies, along with pharmaceutical interventions like corticosteroids and antibiotics, are crucial in managing ARDS symptoms and complications.

Geographical Insights

Americas represent the largest market for ARDS treatments, driven by advanced healthcare infrastructure, significant R&D activities, and a high prevalence of respiratory diseases. The United States is a key market, with extensive use of advanced therapies and a high incidence of ARDS cases.

In the Americas, the market benefits from a mature healthcare system, the presence of leading pharmaceutical and medical device companies, and a strong focus on critical care management. The impact of the COVID-19 pandemic has further emphasized the importance of ARDS treatment capabilities.

The Asia Pacific region is expected to witness the highest growth rate, driven by increasing healthcare investments, rising incidence of respiratory diseases, and growing awareness of critical care management. Countries like China, Japan, and India are key markets, with expanding healthcare infrastructure and a focus on improving patient outcomes.

In Europe, the market for ARDS treatments is driven by strong healthcare systems, high patient awareness, and ongoing research efforts. Countries like Germany, France, and the UK are significant contributors, with a focus on developing new therapies and improving critical care practices.

Market Segmentation

By End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Academic and Research Institutions
  • Specialty Clinics
  • Other End-Users

By Mode of Administration:

  • Intravenous
  • Inhalation
  • Topical
  • Oral

By Treatment Mode:

  • Drugs
  • Devices

By Geography:

  • Americas (The United States, Canada, Brazil, Mexico, Rest of Americas)
  • Europe (United Kingdom, Germany, France, Italy, Spain, Turkey, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, South Korea, India, Singapore, Indonesia, Rest of Asia Pacific)
  • Middle East and Africa (GCC, Israel, South Africa, Rest of Middle East and Africa)

Key Companies

The report assesses the competitive developments, strategies, mergers and acquisitions and new product development and market share portfolio of top 15 companies. Key companies in the Global Acute Respiratory Distress Syndrome Market include:
  • United Therapeutics
  • Athersys
  • GE Healthcare
  • Apeptico Forschung
  • Fisher & Paykel Healthcare Limited
  • NRx Pharmaceuticals, Inc.
  • HEALIOS K.K
  • BioMarck Pharmaceuticals
  • Hamilton Company
  • Faron Pharmaceuticals

Reasons to buy this report:

  • In-Depth Comparative Assessment of Top 20 Markets in the Acute Respiratory Distress Syndrome Market: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.
  • Comprehensive Historical, Present, and Future Analytics of the Acute Respiratory Distress Syndrome Market: A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Acute Respiratory Distress Syndrome Market.
  • Detailed Analysis of Acute Respiratory Distress Syndrome Market By End-User, Mode of Administration, and Treatment Mode Across 20 Countries
  • Beyond the Purchase: 90 Days of Support
  • Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.
  • Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.
  • Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.
  • Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)
  • Strategic Company Movements: Tracking Competitive Developments and Key Players in the Market: The report covers competitive strategies, mergers & acquisitions, new developments, future plans and market share analysis of ~15 top companies.


This product will be delivered within 2 business days.

Table of Contents

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
3. Global Acute Respiratory Distress Syndrome Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Acute Respiratory Distress Syndrome Market
3.2 Acute Respiratory Distress Syndrome Market Type Matrix
3.3 Global Acute Respiratory Distress Syndrome Market: Dashboard
3.4 Global Acute Respiratory Distress Syndrome Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
3.5 Global Acute Respiratory Distress Syndrome Market: Market Value Assessment
3.6 Assessment Degree of Impact of COVID-19 on Global Acute Respiratory Distress Syndrome Market
3.7 Global Acute Respiratory Distress Syndrome Market Segmentation: By End-User
3.7.1 Global Acute Respiratory Distress Syndrome Market, By End-User Overview
3.7.2 Global Acute Respiratory Distress Syndrome Market Attractiveness Index, By End-User (2025-2030)
3.7.3 Global Acute Respiratory Distress Syndrome Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
3.7.4 Global Acute Respiratory Distress Syndrome Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
3.7.5 Global Acute Respiratory Distress Syndrome Market Size, By Academic and Research Institutions, By Value, 2020H-2030F (USD Million & CAGR)
3.7.6 Global Acute Respiratory Distress Syndrome Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
3.7.7 Global Acute Respiratory Distress Syndrome Market Size, By Other End-Users, By Value, 2020H-2030F (USD Million & CAGR)
3.8 Global Acute Respiratory Distress Syndrome Market Segmentation: By Mode of Administration
3.8.1 Global Acute Respiratory Distress Syndrome Market, By Mode of Administration Overview
3.8.2 Global Acute Respiratory Distress Syndrome Market Attractiveness Index, By Mode of Administration (2025-2030)
3.8.3 Global Acute Respiratory Distress Syndrome Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR)
3.8.4 Global Acute Respiratory Distress Syndrome Market Size, By Inhalation, By Value, 2020H-2030F (USD Million & CAGR)
3.8.5 Global Acute Respiratory Distress Syndrome Market Size, By Topical, By Value, 2020H-2030F (USD Million & CAGR)
3.8.6 Global Acute Respiratory Distress Syndrome Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
3.9 Global Acute Respiratory Distress Syndrome Market Segmentation: By Treatment Mode
3.9.1 Global Acute Respiratory Distress Syndrome Market, By Treatment Mode Overview
3.9.2 Global Acute Respiratory Distress Syndrome Market Attractiveness Index, By Treatment Mode (2025-2030)
3.9.3 Global Acute Respiratory Distress Syndrome Market Size, By Drugs, By Value, 2020H-2030F (USD Million & CAGR)
3.9.4 Global Acute Respiratory Distress Syndrome Market Size, By Devices, By Value, 2020H-2030F (USD Million & CAGR)
4. Acute Respiratory Distress Syndrome Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot
5. Americas Acute Respiratory Distress Syndrome Market: Historic and Forecast
5.1 Americas Acute Respiratory Distress Syndrome Market: Snapshot
5.2 Americas Acute Respiratory Distress Syndrome Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
5.3 Americas Acute Respiratory Distress Syndrome Market: Key Factors
5.4 Americas Acute Respiratory Distress Syndrome Market: Segment Analysis
5.5 Americas Acute Respiratory Distress Syndrome Market Segmentation: By End-User
5.5.1 Americas Acute Respiratory Distress Syndrome Market, By End-User Overview
5.5.2 Americas Acute Respiratory Distress Syndrome Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
5.5.3 Americas Acute Respiratory Distress Syndrome Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
5.5.4 Americas Acute Respiratory Distress Syndrome Market Size, By Academic and Research Institutions, By Value, 2020H-2030F (USD Million & CAGR)
5.5.5 Americas Acute Respiratory Distress Syndrome Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
5.5.6 Americas Acute Respiratory Distress Syndrome Market Size, By Other End-Users, By Value, 2020H-2030F (USD Million & CAGR)
5.6 Americas Acute Respiratory Distress Syndrome Market Segmentation: By Mode of Administration
5.6.1 Americas Acute Respiratory Distress Syndrome Market, By Mode of Administration Overview
5.6.2 Americas Acute Respiratory Distress Syndrome Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR)
5.6.3 Americas Acute Respiratory Distress Syndrome Market Size, By Inhalation, By Value, 2020H-2030F (USD Million & CAGR)
5.6.4 Americas Acute Respiratory Distress Syndrome Market Size, By Topical, By Value, 2020H-2030F (USD Million & CAGR)
5.6.5 Americas Acute Respiratory Distress Syndrome Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
5.7 Americas Acute Respiratory Distress Syndrome Market Segmentation: By Treatment Mode
5.7.1 Americas Acute Respiratory Distress Syndrome Market, By Treatment Mode Overview
5.7.2 Americas Acute Respiratory Distress Syndrome Market Size, By Drugs, By Value, 2020H-2030F (USD Million & CAGR)
5.7.3 Americas Acute Respiratory Distress Syndrome Market Size, By Devices, By Value, 2020H-2030F (USD Million & CAGR)
5.8 Americas Acute Respiratory Distress Syndrome Market Segmentation: By Country
5.8.1 Americas Acute Respiratory Distress Syndrome Market, by Country Overview
5.8.2 United States Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.2.1 United States Acute Respiratory Distress Syndrome Market, By End-User
5.8.2.2 United States Acute Respiratory Distress Syndrome Market, By Mode of Administration
5.8.2.3 United States Acute Respiratory Distress Syndrome Market, By Treatment Mode
5.8.3 Canada Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.3.1 Canada Acute Respiratory Distress Syndrome Market, By End-User
5.8.3.2 Canada Acute Respiratory Distress Syndrome Market, By Mode of Administration
5.8.3.3 Canada Acute Respiratory Distress Syndrome Market, By Treatment Mode
5.8.4 Brazil Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.4.1 Brazil Acute Respiratory Distress Syndrome Market, By End-User
5.8.4.2 Brazil Acute Respiratory Distress Syndrome Market, By Mode of Administration
5.8.4.3 Brazil Acute Respiratory Distress Syndrome Market, By Treatment Mode
5.8.5 Mexico Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.5.1 Mexico Acute Respiratory Distress Syndrome Market, By End-User
5.8.5.2 Mexico Acute Respiratory Distress Syndrome Market, By Mode of Administration
5.8.5.3 Mexico Acute Respiratory Distress Syndrome Market, By Treatment Mode
5.8.6 Rest of Americas Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
5.8.6.1 Rest of Americas Acute Respiratory Distress Syndrome Market, By End-User
5.8.6.2 Rest of Americas Acute Respiratory Distress Syndrome Market, By Mode of Administration
5.8.6.3 Rest of Americas Acute Respiratory Distress Syndrome Market, By Treatment Mode
6. Europe Acute Respiratory Distress Syndrome Market: Historic and Forecast
6.1 Europe Acute Respiratory Distress Syndrome Market: Snapshot
6.2 Europe Acute Respiratory Distress Syndrome Market: Market Size and CAGR, BY Value, 2020-2030 (USD Million & CAGR)
6.3 Europe Acute Respiratory Distress Syndrome Market: Key Factors
6.4 Europe Acute Respiratory Distress Syndrome Market: Segment Analysis
6.5 Europe Acute Respiratory Distress Syndrome Market Segmentation: By End-User
6.5.1 Europe Acute Respiratory Distress Syndrome Market, By End-User Overview
6.5.2 Europe Acute Respiratory Distress Syndrome Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
6.5.3 Europe Acute Respiratory Distress Syndrome Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
6.5.4 Europe Acute Respiratory Distress Syndrome Market Size, By Academic and Research Institutions, By Value, 2020H-2030F (USD Million & CAGR)
6.5.5 Europe Acute Respiratory Distress Syndrome Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
6.5.6 Europe Acute Respiratory Distress Syndrome Market Size, By Other End-Users, By Value, 2020H-2030F (USD Million & CAGR)
6.6 Europe Acute Respiratory Distress Syndrome Market Segmentation: By Mode of Administration
6.6.1 Europe Acute Respiratory Distress Syndrome Market, By Mode of Administration Overview
6.6.2 Europe Acute Respiratory Distress Syndrome Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR)
6.6.3 Europe Acute Respiratory Distress Syndrome Market Size, By Inhalation, By Value, 2020H-2030F (USD Million & CAGR)
6.6.4 Europe Acute Respiratory Distress Syndrome Market Size, By Topical, By Value, 2020H-2030F (USD Million & CAGR)
6.6.5 Europe Acute Respiratory Distress Syndrome Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
6.7 Europe Acute Respiratory Distress Syndrome Market Segmentation: By Treatment Mode
6.7.1 Europe Acute Respiratory Distress Syndrome Market, By Treatment Mode Overview
6.7.2 Europe Acute Respiratory Distress Syndrome Market Size, By Drugs, By Value, 2020H-2030F (USD Million & CAGR)
6.7.3 Europe Acute Respiratory Distress Syndrome Market Size, By Devices, By Value, 2020H-2030F (USD Million & CAGR)
6.8 Europe Acute Respiratory Distress Syndrome Market Segmentation: By Country
6.8.1 Europe Acute Respiratory Distress Syndrome Market, by Country Overview
6.8.2 Russia Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.2.1 Russia Acute Respiratory Distress Syndrome Market, By End-User
6.8.2.2 Russia Acute Respiratory Distress Syndrome Market, By Mode of Administration
6.8.2.3 Russia Acute Respiratory Distress Syndrome Market, By Treatment Mode
6.8.3 France Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.3.1 France Acute Respiratory Distress Syndrome Market, By End-User
6.8.3.2 France Acute Respiratory Distress Syndrome Market, By Mode of Administration
6.8.3.3 France Acute Respiratory Distress Syndrome Market, By Treatment Mode
6.8.4 United Kingdom Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.4.1 United Kingdom Acute Respiratory Distress Syndrome Market, By End-User
6.8.4.2 United Kingdom Acute Respiratory Distress Syndrome Market, By Mode of Administration
6.8.4.3 United Kingdom Acute Respiratory Distress Syndrome Market, By Treatment Mode
6.8.5 Germany Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.5.1 Germany Acute Respiratory Distress Syndrome Market, By End-User
6.8.5.2 Germany Acute Respiratory Distress Syndrome Market, By Mode of Administration
6.8.5.3 Germany Acute Respiratory Distress Syndrome Market, By Treatment Mode
6.8.6 Italy Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.6.1 Italy Acute Respiratory Distress Syndrome Market, By End-User
6.8.6.2 Italy Acute Respiratory Distress Syndrome Market, By Mode of Administration
6.8.6.3 Italy Acute Respiratory Distress Syndrome Market, By Treatment Mode
6.8.7 Spain Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.7.1 Spain Acute Respiratory Distress Syndrome Market, By End-User
6.8.7.2 Spain Acute Respiratory Distress Syndrome Market, By Mode of Administration
6.8.7.3 Spain Acute Respiratory Distress Syndrome Market, By Treatment Mode
6.8.8 Turkey Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.8.1 Turkey Acute Respiratory Distress Syndrome Market, By End-User
6.8.8.2 Turkey Acute Respiratory Distress Syndrome Market, By Mode of Administration
6.8.8.3 Turkey Acute Respiratory Distress Syndrome Market, By Treatment Mode
6.8.9 Rest of Europe Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
6.8.9.1 Rest of Europe Acute Respiratory Distress Syndrome Market, By End-User
6.8.9.2 Rest of Europe Acute Respiratory Distress Syndrome Market, By Mode of Administration
6.8.9.3 Rest of Europe Acute Respiratory Distress Syndrome Market, By Treatment Mode
7. Asia Pacific Acute Respiratory Distress Syndrome Market: Historic and Forecast
7.1 Asia Pacific Acute Respiratory Distress Syndrome Market: Snapshot
7.2 Asia Pacific Acute Respiratory Distress Syndrome Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
7.3 Asia Pacific Acute Respiratory Distress Syndrome Market: Key Factors
7.4 Asia Pacific Acute Respiratory Distress Syndrome Market: Segment Analysis
7.5 Asia Pacific Acute Respiratory Distress Syndrome Market Segmentation: By End-User
7.5.1 Asia Pacific Acute Respiratory Distress Syndrome Market, By End-User Overview
7.5.2 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
7.5.3 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
7.5.4 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Academic and Research Institutions, By Value, 2020H-2030F (USD Million & CAGR)
7.5.5 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
7.5.6 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Other End-Users, By Value, 2020H-2030F (USD Million & CAGR)
7.6 Asia Pacific Acute Respiratory Distress Syndrome Market Segmentation: By Mode of Administration
7.6.1 Asia Pacific Acute Respiratory Distress Syndrome Market, By Mode of Administration Overview
7.6.2 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR)
7.6.3 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Inhalation, By Value, 2020H-2030F (USD Million & CAGR)
7.6.4 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Topical, By Value, 2020H-2030F (USD Million & CAGR)
7.6.5 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
7.7 Asia Pacific Acute Respiratory Distress Syndrome Market Segmentation: By Treatment Mode
7.7.1 Asia Pacific Acute Respiratory Distress Syndrome Market, By Treatment Mode Overview
7.7.2 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Drugs, By Value, 2020H-2030F (USD Million & CAGR)
7.7.3 Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Devices, By Value, 2020H-2030F (USD Million & CAGR)
7.8 Asia Pacific Acute Respiratory Distress Syndrome Market Segmentation: By Country
7.8.1 Asia Pacific Acute Respiratory Distress Syndrome Market, by Country Overview
7.8.2 China Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.2.1 China Acute Respiratory Distress Syndrome Market, By End-User
7.8.2.2 China Acute Respiratory Distress Syndrome Market, By Mode of Administration
7.8.2.3 China Acute Respiratory Distress Syndrome Market, By Treatment Mode
7.8.3 India Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.3.1 India Acute Respiratory Distress Syndrome Market, By End-User
7.8.3.2 India Acute Respiratory Distress Syndrome Market, By Mode of Administration
7.8.3.3 India Acute Respiratory Distress Syndrome Market, By Treatment Mode
7.8.4 South Korea Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.4.1 South Korea Acute Respiratory Distress Syndrome Market, By End-User
7.8.4.2 South Korea Acute Respiratory Distress Syndrome Market, By Mode of Administration
7.8.4.3 South Korea Acute Respiratory Distress Syndrome Market, By Treatment Mode
7.8.5 Japan Korea Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.5.1 Japan Acute Respiratory Distress Syndrome Market, By End-User
7.8.5.2 Japan Acute Respiratory Distress Syndrome Market, By Mode of Administration
7.8.5.3 Japan Acute Respiratory Distress Syndrome Market, By Treatment Mode
7.8.6 Singapore Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.6.1 Singapore Acute Respiratory Distress Syndrome Market, By End-User
7.8.6.2 Singapore Acute Respiratory Distress Syndrome Market, By Mode of Administration
7.8.6.3 Singapore Acute Respiratory Distress Syndrome Market, By Treatment Mode
7.8.7 Indonesia Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.7.1 Indonesia Acute Respiratory Distress Syndrome Market, By End-User
7.8.7.2 Indonesia Acute Respiratory Distress Syndrome Market, By Mode of Administration
7.8.7.3 Indonesia Acute Respiratory Distress Syndrome Market, By Treatment Mode
7.8.8 Rest of Asia Pacific Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
7.8.8.1 Rest of Asia Pacific Acute Respiratory Distress Syndrome Market, By End-User
7.8.8.2 Rest of Asia Pacific Acute Respiratory Distress Syndrome Market, By Mode of Administration
7.8.8.3 Rest of Asia Pacific Acute Respiratory Distress Syndrome Market, By Treatment Mode
8. Middle East & Africa Acute Respiratory Distress Syndrome Market: Historic and Forecast
8.1 Middle East & Africa Acute Respiratory Distress Syndrome Market: Snapshot
8.2 Middle East & Africa Acute Respiratory Distress Syndrome Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
8.3 Middle East & Africa Acute Respiratory Distress Syndrome Market: Key Factors
8.4 Middle East and Africa Acute Respiratory Distress Syndrome Market: Segment Analysis
8.5 Middle East & Africa Acute Respiratory Distress Syndrome Market Segmentation: By End-User
8.5.1 Middle East & Africa Acute Respiratory Distress Syndrome Market, By End-User Overview
8.5.2 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
8.5.3 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
8.5.4 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Academic and Research Institutions, By Value, 2020H-2030F (USD Million & CAGR)
8.5.5 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
8.5.6 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Other End-Users, By Value, 2020H-2030F (USD Million & CAGR)
8.6 Middle East & Africa Acute Respiratory Distress Syndrome Market Segmentation: By Mode of Administration
8.6.1 Middle East & Africa Acute Respiratory Distress Syndrome Market, By Mode of Administration Overview
8.6.2 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR)
8.6.3 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Inhalation, By Value, 2020H-2030F (USD Million & CAGR)
8.6.4 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Topical, By Value, 2020H-2030F (USD Million & CAGR)
8.6.5 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
8.7 Middle East & Africa Acute Respiratory Distress Syndrome Market Segmentation: By Treatment Mode
8.7.1 Middle East & Africa Acute Respiratory Distress Syndrome Market, By Treatment Mode Overview
8.7.2 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Drugs, By Value, 2020H-2030F (USD Million & CAGR)
8.7.3 Middle East & Africa Acute Respiratory Distress Syndrome Market Size, By Devices, By Value, 2020H-2030F (USD Million & CAGR)
8.8 Middle East & Africa Acute Respiratory Distress Syndrome Market Segmentation: By Country
8.8.1 Middle East & Africa Acute Respiratory Distress Syndrome Market, by Country Overview
8.8.2 GCC Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.2.1 GCC Acute Respiratory Distress Syndrome Market, By End-User
8.8.2.2 GCC Acute Respiratory Distress Syndrome Market, By Mode of Administration
8.8.2.3 GCC Acute Respiratory Distress Syndrome Market, By Treatment Mode
8.8.3 Israel Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.3.1 Israel Acute Respiratory Distress Syndrome Market, By End-User
8.8.3.2 Israel Acute Respiratory Distress Syndrome Market, By Mode of Administration
8.8.3.3 Israel Acute Respiratory Distress Syndrome Market, By Treatment Mode
8.8.4 South Africa Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.4.1 South Africa Acute Respiratory Distress Syndrome Market, By End-User
8.8.4.2 South Africa Acute Respiratory Distress Syndrome Market, By Mode of Administration
8.8.4.3 South Africa Acute Respiratory Distress Syndrome Market, By Treatment Mode
8.8.5 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market: Market Size and CAGR, 2020-2030 (USD Million & CAGR)
8.8.5.1 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market, By End-User
8.8.5.2 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market, By Mode of Administration
8.8.5.3 Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market, By Treatment Mode
9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Acute Respiratory Distress Syndrome Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Ecosystem Analysis
10.1 Porter Analysis
11. Competitive Positioning
11.1 Companies’ Competitive Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Acute Respiratory Distress Syndrome Market
11.4 Company Profiles
11.4.1 United Therapeutics
11.4.2 Athersys
11.4.3 GE Healthcare
11.4.4 Apeptico Forschung
11.4.5 Fisher & Paykel Healthcare Limited
11.4.6 NRx Pharmaceuticals, Inc.
11.4.7 HEALIOS K.K
11.4.8 BioMarck Pharmaceuticals
11.4.9 Hamilton Company
11.4.10 Faron Pharmaceuticals
11.4.11 Other Leading Companies
12. About the Publisher & Disclaimer
List of Figures
Figure 1: Acute Respiratory Distress Syndrome Market, Comparison of Leading Countries, 2023 (%)
Figure 2: Acute Respiratory Distress Syndrome Market, Comparison of Leading Countries, 2030 (%)
Figure 3: Acute Respiratory Distress Syndrome Market Type Matrix
Figure 4: Acute Respiratory Distress Syndrome Market Demand Analysis
Figure 5: Global Acute Respiratory Distress Syndrome Market Size, By Value, 2020-2023 (USD Million)
Figure 6: Global Acute Respiratory Distress Syndrome Market Size, By Value, 2024-2030 (USD Million)
Figure 7: Global Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, 2023 (%)
Figure 8: Global Acute Respiratory Distress Syndrome Market CAGR, 2020-2023 (%)
Figure 9: Global Acute Respiratory Distress Syndrome Market CAGR, 2025-2030 (%)
Figure 10: Global Acute Respiratory Distress Syndrome Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 11: Market Attractiveness Analysis of Global Acute Respiratory Distress Syndrome Market, By End-User (2025-2030)
Figure 12: Global Acute Respiratory Distress Syndrome Market Size, By Hospitals, By Value, 2020H-2030F (USD Million & CAGR)
Figure 13: Global Acute Respiratory Distress Syndrome Market Absolute Opportunity, By Hospitals, 2020-2030 (USD Million)
Figure 14: Global Acute Respiratory Distress Syndrome Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
Figure 15: Global Acute Respiratory Distress Syndrome Market Absolute Opportunity, By Ambulatory Surgical Centers, 2020-2030 (USD Million)
Figure 16: Global Acute Respiratory Distress Syndrome Market Size, By Academic and Research Institutions, By Value, 2020H-2030F (USD Million & CAGR)
Figure 17: Global Acute Respiratory Distress Syndrome Market Absolute Opportunity, By Academic and Research Institutions, 2020-2030 (USD Million)
Figure 18: Global Acute Respiratory Distress Syndrome Market Size, By Specialty Clinics, By Value, 2020H-2030F (USD Million & CAGR)
Figure 19: Global Acute Respiratory Distress Syndrome Market Absolute Opportunity, By Specialty Clinics, 2020-2030 (USD Million)
Figure 20: Global Acute Respiratory Distress Syndrome Market Size, By Other End-Users, By Value, 2020H-2030F (USD Million & CAGR)
Figure 21: Global Acute Respiratory Distress Syndrome Market Absolute Opportunity, By Other End-Users, 2020-2030 (USD Million)
Figure 22: Market Attractiveness Analysis of Global Acute Respiratory Distress Syndrome Market, By Mode of Administration (2025-2030)
Figure 23: Global Acute Respiratory Distress Syndrome Market Size, By Intravenous, By Value, 2020H-2030F (USD Million & CAGR)
Figure 24: Global Acute Respiratory Distress Syndrome Market Absolute Opportunity, By Intravenous, 2020-2030 (USD Million)
Figure 25: Global Acute Respiratory Distress Syndrome Market Size, By Inhalation, By Value, 2020H-2030F (USD Million & CAGR)
Figure 26: Global Acute Respiratory Distress Syndrome Market Absolute Opportunity, By Inhalation, 2020-2030 (USD Million)
Figure 27: Global Acute Respiratory Distress Syndrome Market Size, By Topical, By Value, 2020H-2030F (USD Million & CAGR)
Figure 28: Global Acute Respiratory Distress Syndrome Market Absolute Opportunity, By Topical, 2020-2030 (USD Million)
Figure 29: Global Acute Respiratory Distress Syndrome Market Size, By Oral, By Value, 2020H-2030F (USD Million & CAGR)
Figure 30: Global Acute Respiratory Distress Syndrome Market Absolute Opportunity, By Oral, 2020-2030 (USD Million)
Figure 31: Market Attractiveness Analysis of Global Acute Respiratory Distress Syndrome Market, By Treatment Mode (2025-2030)
Figure 32: Global Acute Respiratory Distress Syndrome Market Size, By Drugs, By Value, 2020H-2030F (USD Million & CAGR)
Figure 33: Global Acute Respiratory Distress Syndrome Market Absolute Opportunity, By Drugs, 2020-2030 (USD Million)
Figure 34: Global Acute Respiratory Distress Syndrome Market Size, By Devices, By Value, 2020H-2030F (USD Million & CAGR)
Figure 35: Global Acute Respiratory Distress Syndrome Market Absolute Opportunity, By Devices, 2020-2030 (USD Million)
Figure 36: Americas Acute Respiratory Distress Syndrome Market Size, By Value, 2020H-2030F (USD Million)
Figure 37: Americas Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, 2023 (%)
Figure 38: Americas Acute Respiratory Distress Syndrome Market Share, By New Product Launches, 2023 (%)
Figure 39: Americas Acute Respiratory Distress Syndrome Market Share, By Company, 2023 (%)
Figure 40: Americas Acute Respiratory Distress Syndrome Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 41: Americas Acute Respiratory Distress Syndrome Market, By Hospitals, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 42: Americas Acute Respiratory Distress Syndrome Market, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 43: Americas Acute Respiratory Distress Syndrome Market, By Academic and Research Institutions, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 44: Americas Acute Respiratory Distress Syndrome Market, By Specialty Clinics, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 45: Americas Acute Respiratory Distress Syndrome Market, By Other End-Users, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 46: Figure 46: Americas Acute Respiratory Distress Syndrome Market, By Intravenous, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 47: Americas Acute Respiratory Distress Syndrome Market, By Inhalation, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 48: Americas Acute Respiratory Distress Syndrome Market, By Academic and Research Institutions, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 49: Americas Acute Respiratory Distress Syndrome Market, By Oral, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 50: Americas Acute Respiratory Distress Syndrome Market, By Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 51: Americas Acute Respiratory Distress Syndrome Market, By Devices, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 52: United States Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 53: United States Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 54: United States Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 55: United States Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 56: United States Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 57: Canada Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 58: Canada Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 59: Canada Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 60: Canada Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 61: Canada Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 62: Brazil Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 63: Brazil Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 64: Brazil Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 65: Brazil Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 66: Brazil Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 67: Mexico Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 68: Mexico Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 69: Mexico Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 70: Mexico Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 71: Mexico Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 72: Rest of Americas Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 73: Rest of Americas Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 74: Rest of Americas Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 75: Rest of Americas Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 76: Rest of Americas Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 77: Europe Acute Respiratory Distress Syndrome Market Size, By Value, 2020H-2030F (USD Million)
Figure 78: Europe Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, 2023 (%)
Figure 79: Europe Acute Respiratory Distress Syndrome Market Share, By New Product Launches, 2023 (%)
Figure 80: Europe Acute Respiratory Distress Syndrome Market Share, By Company, 2023 (%)
Figure 81: Europe Acute Respiratory Distress Syndrome Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 82: Europe Acute Respiratory Distress Syndrome Market, By Hospitals, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 83: Europe Acute Respiratory Distress Syndrome Market, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 84: Europe Acute Respiratory Distress Syndrome Market, By Academic and Research Institutions, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 85: Europe Acute Respiratory Distress Syndrome Market, By Specialty Clinics, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 86: Europe Acute Respiratory Distress Syndrome Market, By Other End-Users, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 87: Europe Acute Respiratory Distress Syndrome Market, By Intravenous, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 88: Europe Acute Respiratory Distress Syndrome Market, By Inhalation, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 89: Europe Acute Respiratory Distress Syndrome Market, By Topical, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 90: Europe Acute Respiratory Distress Syndrome Market, By Oral, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 91: Europe Acute Respiratory Distress Syndrome Market, By Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 92: Europe Acute Respiratory Distress Syndrome Market, By Devices, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 93: Russia Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 94: Russia Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 95: Russia Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 96: Russia Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 97: Russia Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 98: France Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 99: France Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 100: France Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 101: France Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 102: France Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 103: United Kingdom Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 104: United Kingdom Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 105: United Kingdom Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 106: United Kingdom Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 107: United Kingdom Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 108: Germany Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 109: Germany Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 110: Germany Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 111: Germany Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 112: Germany Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 113: Italy Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 114: Italy Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 115: Italy Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 116: Italy Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 117: Italy Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 118: Spain Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 119: Spain Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 120: Spain Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 121: Spain Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 122: Spain Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 123: Turkey Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 124: Turkey Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 125: Turkey Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 126: Turkey Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 127: Turkey Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 128: Rest of Europe Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 129: Rest of Europe Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 130: Rest of Europe Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 131: Rest of Europe Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 132: Rest of Europe Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 133: Asia Pacific Acute Respiratory Distress Syndrome Market Size, By Value, 2020H-2030F (USD Million)
Figure 134: Asia Pacific Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, 2023 (%)
Figure 135: Asia Pacific Acute Respiratory Distress Syndrome Market Share, By New Product Launches, 2023 (%)
Figure 136: Asia Pacific Acute Respiratory Distress Syndrome Market Share, By Company, 2023 (%)
Figure 137: Asia Pacific Acute Respiratory Distress Syndrome Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 138: Asia Pacific Acute Respiratory Distress Syndrome Market, By Hospitals, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 139: Asia Pacific Acute Respiratory Distress Syndrome Market, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 140: Asia Pacific Acute Respiratory Distress Syndrome Market, By Academic and Research Institutions, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 141: Asia Pacific Acute Respiratory Distress Syndrome Market, By Specialty Clinics, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 142: Asia Pacific Acute Respiratory Distress Syndrome Market, By Other End-Users, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 143: Asia Pacific Acute Respiratory Distress Syndrome Market, By Intravenous, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 144: Asia Pacific Acute Respiratory Distress Syndrome Market, By Inhalation, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 145: Asia Pacific Acute Respiratory Distress Syndrome Market, By Topical, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 146: Asia Pacific Acute Respiratory Distress Syndrome Market, By Oral, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 147: Asia Pacific Acute Respiratory Distress Syndrome Market, By Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 148: Asia Pacific Acute Respiratory Distress Syndrome Market, By Devices, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 149: China Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 150: China Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 151: China Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 152: China Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 153: China Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 154: India Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 155: India Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 156: India Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 157: India Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 158: India Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 159: South Korea Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 160: South Korea Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 161: South Korea Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 162: South Korea Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 163: South Korea Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 164: Japan Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 165: Japan Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 166: Japan Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 167: Japan Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 168: Japan Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 169: Singapore Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 170: Singapore Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 171: Singapore Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 172: Singapore Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 173: Singapore Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 174: Indonesia Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 175: Indonesia Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 176: Indonesia Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 177: Indonesia Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 178: Indonesia Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 179: Rest of Asia Pacific Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 180: Rest of Asia Pacific Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 181: Rest of Asia Pacific Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 182: Rest of Asia Pacific Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 183: Rest of Asia Pacific Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 184: Middle East and Africa Acute Respiratory Distress Syndrome Market Size, By Value, 2020H-2030F (USD Million)
Figure 185: Middle East and Africa Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, 2023 (%)
Figure 186: Middle East and Africa Acute Respiratory Distress Syndrome Market Share, By New Product Launches, 2023 (%)
Figure 187: Middle East and Africa Acute Respiratory Distress Syndrome Market Share, By Company, 2023 (%)
Figure 188: Middle East and Africa Acute Respiratory Distress Syndrome Market CAGR (%), By Region, 2020-2023, 2025-2030
Figure 189: Middle East and Africa Acute Respiratory Distress Syndrome Market, By Hospitals, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 190: Middle East and Africa Acute Respiratory Distress Syndrome Market, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 191: Middle East and Africa Acute Respiratory Distress Syndrome Market, By Academic and Research Institutions, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 192: Middle East and Africa Acute Respiratory Distress Syndrome Market, By Specialty Clinics, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 193: Middle East and Africa Acute Respiratory Distress Syndrome Market, By Other End-Users, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 194: Middle East and Africa Acute Respiratory Distress Syndrome Market, By Intravenous, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 195: Middle East and Africa Acute Respiratory Distress Syndrome Market, By Inhalation, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 196: Middle East and Africa Acute Respiratory Distress Syndrome Market, By Topical, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 197: Middle East and Africa Acute Respiratory Distress Syndrome Market, By Oral, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 198: Middle East and Africa Acute Respiratory Distress Syndrome Market, By Drugs, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 199: Middle East and Africa Acute Respiratory Distress Syndrome Market, By Devices, By Value, 2020H-2030F (USD Millions & CAGR)
Figure 200: GCC Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 201: GCC Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 202: GCC Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 203: GCC Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 204: GCC Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 205: Israel Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 206: Israel Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 207: Israel Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 208: Israel Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 209: Israel Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 210: South Africa Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 211: South Africa Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 212: South Africa Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 213: South Africa Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 214: South Africa Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 215: Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market, By Value, 2020-2030 (USD Million & CAGR)
Figure 216: Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market Value, By Treatment Mode, 2023 (USD Million)
Figure 217: Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market Share, By End-User, By Value, 2023 (%)
Figure 218: Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market Share, By Mode of Administration, By Value, 2023 (%)
Figure 219: Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market Share, By Treatment Mode, By Value, 2023 (%)
Figure 220: Market Share of Prominent Companies of Global Acute Respiratory Distress Syndrome Market, 2023 (%)
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A3: United States Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A4: United States Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A5: United States Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A6: United States Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A7: United States Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A8: Canada Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A9: Canada Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024- 2030 (USD Million)
Table A10: Canada Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A11: Canada Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A12: Canada Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A13: Canada Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A14: Brazil Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A15: Brazil Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A16: Brazil Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A17: Brazil Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A18: Brazil Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A19: Brazil Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A20: Mexico Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A21: Mexico Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A22: Mexico Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A23: Mexico Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A24: Mexico Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A25: Mexico Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A26: Rest of Americas Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A27: Rest of Americas Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A28: Rest of Americas Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A29: Rest of Americas Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A30: Rest of Americas Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A31: Rest of Americas Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A32: Russia Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A33: Russia Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A34: Russia Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A35: Russia Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A36: Russia Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A37: Russia Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A38: France Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A39: France Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A40: France Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A41: France Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A42: France Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A43: France Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A44: United Kingdom Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A45: United Kingdom Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A46: United Kingdom Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A47: United Kingdom Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A48: United Kingdom Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A49: United Kingdom Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A50: Germany Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A51: Germany Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A52: Germany Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A53: Germany Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A54: Germany Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A55: Germany Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A56: Italy Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A57: Italy Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A58: Italy Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A59: Italy Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A60: Italy Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A61: Italy Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A62: Spain Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A63: Spain Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A64: Spain Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A65: Spain Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A66: Spain Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A67: Spain Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A68: Turkey Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A69: Turkey Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A70: Turkey Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A71: Turkey Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A72: Turkey Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A73: Turkey Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A74: Rest of Europe Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A75: Rest of Europe Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A76: Rest of Europe Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A77: Rest of Europe Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A78: Rest of Europe Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A79: Rest of Europe Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A80: China Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A81: China Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A82: China Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A83: China Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A84: China Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A85: China Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A86: India Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A87: India Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A88: India Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A89: India Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A90: India Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A91: India Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A92: South Korea Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A93: South Korea Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A94: South Korea Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A95: South Korea Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A96: South Korea Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A97: South Korea Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A98: Japan Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A99: Japan Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A100: Japan Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A101: Japan Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A102: Japan Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A103: Japan Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A104: Singapore Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A105: Singapore Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A106: Singapore Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A107: Singapore Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A108: Singapore Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A109: Singapore Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A110: Indonesia Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A111: Indonesia Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A112: Indonesia Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A113: Indonesia Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A114: Indonesia Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A115: Indonesia Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A116: Rest of Asia Pacific Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A117: Rest of Asia Pacific Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A118: Rest of Asia Pacific Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A119: Rest of Asia Pacific Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A120: Rest of Asia Pacific Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A121: Rest of Asia Pacific Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A122: GCC Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A123: GCC Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A124: GCC Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A125: GCC Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A126: GCC Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A127: GCC Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A128: Israel Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A129: Israel Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A130: Israel Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A131: Israel Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A132: Israel Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A133: Israel Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A134: South Africa Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A135: South Africa Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A136: South Africa Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A137: South Africa Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A138: South Africa Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A139: South Africa Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)
Table A140: Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2020-2023 (USD Million)
Table A141: Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market, By End-User, By Value, 2024-2030 (USD Million)
Table A142: Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2020-2023 (USD Million)
Table A143: Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market, By Mode of Administration, By Value, 2024-2030 (USD Million)
Table A144: Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2020-2023 (USD Million)
Table A145: Rest of Middle East and Africa Acute Respiratory Distress Syndrome Market, By Treatment Mode, By Value, 2024-2030 (USD Million)

Companies Mentioned

  • United Therapeutics
  • Athersys
  • GE Healthcare
  • Apeptico Forschung
  • Fisher & Paykel Healthcare Limited
  • NRx Pharmaceuticals, Inc.
  • HEALIOS K.K
  • BioMarck Pharmaceuticals
  • Hamilton Company
  • Faron Pharmaceuticals

Related Topics

Related Reports

Acute Respiratory Distress Syndrome Market by Type, Cause, End-user - Global Forecast 2025-2030 - Product Image

Acute Respiratory Distress Syndrome Market by Type, Cause, End-user - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Acute Respiratory Distress Syndrome (ARDS) Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Acute Respiratory Distress Syndrome (ARDS) Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 130 Pages
  • Global
From
Acute Respiratory Distress Syndrome Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Acute Respiratory Distress Syndrome Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 191 Pages
  • Global
From
Acute Respiratory Distress Syndrome (ARDS) Global Market Report 2024 - Product Image

Acute Respiratory Distress Syndrome (ARDS) Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Acute Respiratory Distress Syndrome Treatment - Global Strategic Business Report - Product Image

Acute Respiratory Distress Syndrome Treatment - Global Strategic Business Report

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.